Moleculin Biotech, Inc. (MBRX)

NASDAQ: MBRX · Real-Time Price · USD

2.500

-0.030 (-1.19%)

At close: Apr 22, 2026, 4:00 PM EDT

2.460

-0.040 (-1.60%)

Pre-market: Apr 23, 2026, 7:41 AM EDT

Moleculin Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	9.12	8.79	10.02	11.54	8.39
Depreciation & Amortization Expenses	0.09	0.13	0.13	0.13	0.16
Research & Development	15.89	17.73	19.49	18.97	14.42
Total Operating Expenses	25.1	26.64	29.63	30.64	22.97
Operating Income	-25.1	-26.64	-29.63	-30.64	-22.97
Interest Income	0.11	0.55	1.37	0.24	0.31
Other Non-Operating Income (Expense)	-4.52	0.04	-1.51	1.38	6.77
Total Non-Operating Income (Expense)	-4.42	0.59	-0.14	1.62	7.07
Pretax Income	-29.52	-26.05	-29.77	-29.03	-15.89
Net Income	-67.22	-52.1	-29.77	-29.03	-15.89
Net Income Attributable to Preferred Dividends	0.1	-	-	-	-
Net Income to Common	-67.22	-52.1	-29.77	-29.03	-15.89
Shares Outstanding (Basic)	1	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0
Shares Change (YoY)	760.13%	74.28%	3.60%	6.43%	172.97%
EPS (Basic)	-28.42	-189.14	-376.75	-380.50	-221.25
EPS (Diluted)	-28.42	-189.14	-376.75	-380.50	-221.25
Shares Outstanding	3.2	0.14	0.09	0.08	0.08
Free Cash Flow	-22.74	-23.88	-23.72	-27.71	-18.97
Free Cash Flow Per Share	-19.19	-173.36	-300.10	-363.22	-264.69
EBITDA	-25.01	-26.52	-29.5	-30.51	-22.8
EBIT	-25.1	-26.64	-29.63	-30.64	-22.97

Updated Mar 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q